Caxton Associates (New York)’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DVA
Caxton Associates (New York)'s DVA Position: Q4 2024 in Review
Caxton Associates (New York) reduced its DaVita (DVA) stake by 36% in Q4 2024, selling an estimated $627K and leaving 7,260 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #198.
Caxton Associates (New York) first reported a position in DVA in Q1 2014 and has held it in 8 quarters since. The position peaked at $5.05M in Q4 2019. 597 funds tracked by Wall St. Rank hold DVA as of Q4 2024.
- Caxton Associates (New York) held 7,260 shares of DaVita worth $1.09M as of Q4 2024.
- Caxton Associates (New York) sold 3,998 DaVita shares in Q4 2024, an estimated $627K.
- DaVita made up 0.03% of Caxton Associates (New York)'s portfolio in Q4 2024, its #198 holding.
- Caxton Associates (New York) first reported a position in DaVita in Q1 2014 and has held it in 8 quarters since.
- Caxton Associates (New York)'s DaVita position peaked at $5.05M in Q4 2019.
- 597 funds tracked by Wall St. Rank held DaVita as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.